Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A

Haemophilia. 2017 Jan;23(1):e43-e46. doi: 10.1111/hae.13131. Epub 2016 Dec 11.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Cross-Over Studies
  • Factor VIII / therapeutic use*
  • Hemophilia A / drug therapy*
  • Humans
  • Male
  • Pilot Projects

Substances

  • Factor VIII